NCT01588782View on ClinicalTrials.gov

A Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of Abiraterone Following Administration of Abiraterone Acetate Tablets in Healthy Adult Men

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

February 29, 2012

Study Completion Date

February 29, 2012

Conditions
Healthy Volunteers
Interventions
DRUG

Period 1: Abiraterone

1000 mg abiraterone acetate tablet administered orally on Day 1

DRUG

Period 2: Abiraterone/Ketoconazole

400 mg ketoconazole tablets administered orally on Days 11 to 16

DRUG

Period 2: Abiraterone/Ketoconazole

1000 mg abiraterone acetate tablet administered orally on Day 14

Trial Locations (1)

Unknown

Merksem

All Listed Sponsors
lead

Janssen Research & Development, LLC

INDUSTRY

NCT01588782 - A Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of Abiraterone Following Administration of Abiraterone Acetate Tablets in Healthy Adult Men | Biotech Hunter | Biotech Hunter